Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

[C-11]NPA PET-amphetamine in Cocaine Use Disorders (Aim 2)

NCT05011760 is registered in ClinicalTrials.gov with Rajesh Narendran as lead sponsor.

NCT NCT05011760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05011760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
[C-11]NPA PET-amphetamine in Cocaine Use Disorders (Aim 2)
Lead sponsor
Rajesh Narendran
Phase
Phase 1
Overall status
Recruiting
Start date
January 31, 2021
Completion date
September 1, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cocaine use disorder